Insider Trading & Ownership - Yarema Kristin

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Yarema Kristin
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
Company Symbol Insider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2021-06-11
Purchase
2021-06-15
4:02 pm
Atara Biotherapeutics Inc. ATRA Yarema Kristin
Chief Commercial Officer
34,354 $14.57 $500,370 125,882
(Direct)
View
2021-05-18
Sale
2021-05-20
4:29 pm
Atara Biotherapeutics Inc. ATRA Yarema Kristin
Chief Commercial Officer
761 $14.55 $11,073 91,528
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
Company Symnbol Insider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2025-01-08
Equity Swap
2025-01-08
2:07 pm
N/A
N/A
Poseida Therapeutics Inc. PSTX Yarema Kristin
President and CEO
615,836 $0 0
(Direct)
View
2024-01-02
Option Award
2024-01-04
4:03 pm
N/A
2034-01-01
Poseida Therapeutics Inc. PSTX Yarema Kristin
President and CEO
595,200 $0 952,036
(Direct)
View
2023-04-11
Option Award
2023-04-12
4:49 pm
N/A
2033-04-10
Poseida Therapeutics Inc. PSTX Yarema Kristin
President, Cell Therapy
855,161 $0 855,161
(Direct)
View
2022-03-01
Option Award
2022-03-03
7:02 pm
N/A
2032-02-28
Atara Biotherapeutics Inc. ATRA Yarema Kristin
Chief Commercial Officer
131,125 $0 257,007
(Direct)
View
2021-03-01
Option Award
2021-03-03
5:15 pm
N/A
2031-02-28
Atara Biotherapeutics Inc. ATRA Yarema Kristin
Chief Commercial Officer
87,883 $0 145,151
(Direct)
View